Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4592672
Max Phase: Preclinical
Molecular Formula: C59H115N9O10S
Molecular Weight: 1142.69
Molecule Type: Unknown
Associated Items:
ID: ALA4592672
Max Phase: Preclinical
Molecular Formula: C59H115N9O10S
Molecular Weight: 1142.69
Molecule Type: Unknown
Associated Items:
Canonical SMILES: CCCCCCCCCCCCCCCCOC(=O)NCCSC[C@H](NC(=O)CCCCCCCCCCCCCCC)C(=O)N[C@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O
Standard InChI: InChI=1S/C59H115N9O10S/c1-3-5-7-9-11-13-15-17-19-21-23-25-27-35-44-78-59(77)63-43-45-79-47-52(64-53(70)39-28-26-24-22-20-18-16-14-12-10-8-6-4-2)57(74)68-51(46-69)56(73)66-48(36-29-32-40-60)54(71)65-49(37-30-33-41-61)55(72)67-50(58(75)76)38-31-34-42-62/h48-52,69H,3-47,60-62H2,1-2H3,(H,63,77)(H,64,70)(H,65,71)(H,66,73)(H,67,72)(H,68,74)(H,75,76)/t48-,49-,50-,51+,52-/m0/s1
Standard InChI Key: GVUGRBXCTKIEHM-DLMHBMBKSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 1142.69 | Molecular Weight (Monoisotopic): 1141.8488 | AlogP: | #Rotatable Bonds: |
Polar Surface Area: | Molecular Species: | HBA: | HBD: |
#RO5 Violations: | HBA (Lipinski): | HBD (Lipinski): | #RO5 Violations (Lipinski): |
CX Acidic pKa: | CX Basic pKa: | CX LogP: | CX LogD: |
Aromatic Rings: | Heavy Atoms: | QED Weighted: | Np Likeness Score: |
1. Du X, Qian J, Wang Y, Zhang M, Chu Y, Li Y.. (2019) Identification and immunological evaluation of novel TLR2 agonists through structure optimization of Pam3CSK4., 27 (13): [PMID:31101493] [10.1016/j.bmc.2019.05.005] |
Source(1):